Loading…
Loading…
As of 20 Nov 2026: ENNATURE ₹167.65 (m-cap ₹374 Cr, P/E 373.9) vs Vivo Bio Tech ₹16.01 (m-cap ₹35.54 Cr). Compare ROE, ROCE, growth, debt, dividends and 1-year returns.
As of · NSE prices; ratios from company filings
| Metric | ENNATURE | Vivo Bio Tech |
|---|---|---|
| Share price | ₹167.65 | ₹16.01 |
| Day change | −6.03% | +11.80% |
| Market cap | ₹374 Cr | ₹35.54 Cr |
| P/EPrice ÷ trailing 12-month earnings per share; blank for a loss. | 373.9 | — |
| P/BPrice ÷ book value per share. | — | 0.4 |
| ROEReturn on equity. | — | -2.2% |
| ROCEReturn on capital employed. | — | 7.7% |
| Sales growth (3Y CAGR) | — | 0.7% |
| Profit growth (3Y CAGR) | — | — |
| Debt to equity | 0.00 | 0.72 |
| Dividend yield | 0.00% | 0.00% |
| 1-year price return | — | −49.2% |
| Promoter holding | 59.6% | 30.6% |
| Industry | Biotechnology | Biotechnology |
Open in the compare tool for price charts from one month to five years, scorecards and more companies.
Each line states which company has the higher or lower figure; none of them is a recommendation.
Ennature Bio Pharma Ltd is larger, with a market cap of ₹374 Cr against ₹35.54 Cr for Vivo Bio Tech Ltd as of 20 Nov 2026 — about 10.5 times the size.
Vivo Bio Tech Ltd has no meaningful P/E right now (a loss over the last twelve months, or no reported earnings), so the two cannot be compared on P/E.
Jivani Markets does not give buy, sell or hold recommendations and is not a SEBI-registered investment adviser or research analyst. The table on this page lays out the facts side by side — price, valuation, returns on capital, growth, debt, dividends and promoter holding — so you can weigh them against your own goals, or with a SEBI-registered adviser.
Prices refresh every few minutes during market hours and ratios update when the companies report results. Each number is the same one shown on the two stock pages.